Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

NCT04703842 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure
Heart Failure, Systolic
Heart Failure
HFrEF - Heart Failure With Reduced Ejection Fraction

Interventions

BIOLOGICAL: SRD-001
DRUG: Placebo

Sponsor

Sardocor Corp.